Search Browse Earnings

ZEVRA THERAPEUTICS, INC. — SlamSEC

ZEVRA THERAPEUTICS, INC.

Nasdaq:ZVRA

Pharmaceutical Preparations·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Mcfarlane Neil F.

Revenue

$0

FY 2015

Adj. EBITDA

-$80.6M

FY 2025

Net Income

-$105.5M

FY 2025

EPS (Diluted)

-$2.28

FY 2025

Stock Price

$11.06

+21.3%

2026-03-10

52W Range

$6.19 – $13.16

P/E Ratio

-4.9x

Market Cap

$649.4M

Cash

$33.8M

FY 2025

Total Debt

$59.5M

FY 2025

Net Debt

$25.7M

FY 2025

Enterprise Value

$675.1M

Debt / EBITDA

-0.3x

FY 2015

EV / EBITDA

-8.4x

Employees

—